External site

By following this link, you are leaving Medically and entering a website that is not owned or controlled by Roche. Roche does not take any responsibility for access to or use of this website, nor for any content therein.

Roche and Genentech at

Cure SMA 2022

June 16 - June 19

Anaheim, USA

curesma.org

Add to calendar

Medical Materials

Agenda

Highlights

Coming soon

10:40 AM

Duration 20mins The Sequoia ballroom (Grand Californian Hotel)

RAINBOWFISH: Preliminary efficacy and safety data in risdiplam▼-treated infants with presymptomatic spinal muscular atrophy (SMA)

Richard S Finkel, Michelle A Farrar, Dmitry Vlodavets, Edmar Zanoteli, Mohammad Al-Muhaizea, Leslie Nelson, Alexandra Prufer, Laurent Servais, Yi Wang, Carolyn Fisher, Marianne Gerber, Ksenija Gorni, Heidemarie Kletzl, Laura Palfreeman, Renata S Scalco, Enrico Bertini, on behalf of the RAINBOWFISH Study Group

Neuroscience | Spinal Muscular Atrophy

Add to calendar

11:00 AM

Duration 20mins The Sequoia ballroom (Grand Californian Hotel)

FIREFISH Parts 1 and 2: 36-month safety and efficacy of risdiplam▼ in Type 1 spinal muscular atrophy (SMA)

Laurent Servais, Giovanni Baranello, Odile Boespflug-Tanguy, John W Day, Nicolas Deconinck, Andrea Klein, Riccardo Masson, Maria Mazurkiewicz-Beldzinska, Eugenio Mercuri, Kirsty Rose, Dmitry Vlodavets, Hui Xiong, Edmar Zanoteli, Muna El-Khairi, Marianne Gerber, Ksenija Gorni, Heidemarie Kletzl, Angela Dodman, Eleni Gaki, Basil T Darras, on behalf of the FIREFISH Working Group

Neuroscience | Spinal Muscular Atrophy

Add to calendar

Follow us here

This website is intended for healthcare professionals outside the United Kingdom (UK) and Australia. Registration status and prescribing information of medicinal products may differ between countries. Please refer to local product information for any medicinal products mentioned on this website.